{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T17:45:55Z","timestamp":1765302355099,"version":"3.46.0"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,3]]},"abstract":"<jats:title>Lay Summary<\/jats:title>\n                  <jats:p>An editorial commentary on management options for coccidioidal meningitis with recent increasing concerns about fluconazole failure. We favor the use of mold-active azoles with mild symptoms of relapse or progression, and initiation of intrathecal amphotericin B for severe disease.<\/jats:p>","DOI":"10.1093\/jpids\/piaf106","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:49:38Z","timestamp":1763470178000},"source":"Crossref","is-referenced-by-count":0,"title":["Coccidioidal Meningitis in Children: Should Intravenous Liposomal Amphotericin be Added to Fluconazole Therapy?"],"prefix":"10.1093","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2485-3927","authenticated-orcid":false,"given":"Sanchi","family":"Malhotra","sequence":"first","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Department of Pediatrics, University of California Los Angeles , Los Angeles, CA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Krogstad","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Department of Pediatrics, University of California Los Angeles , Los Angeles, CA ,","place":["United States"]},{"name":"Division of Molecular and Medical Pharmacology, Department of Pediatrics, University of California Los Angeles , Los Angeles, CA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"2025120912413434400_ref1","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1093\/cid\/ciw360","article-title":"Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2025120912413434400_ref2","first-page":"339-343","article-title":"Coccidioidal meningitis. The use of amphotericin B in treatment","volume":"94","author":"Einstein","year":"1961","journal-title":"Calif Med"},{"key":"2025120912413434400_ref3","volume-title":"Red Book: 2024 Report of the Committee on Infectious Diseases","author":"Kimberlin","year":"2024.","edition":"33rd"},{"key":"2025120912413434400_ref4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/jac\/dkm264","article-title":"Efficacy of amphotericin B lipid complex in a rabbit model of coccidioidal meningitis","volume":"60","author":"Capilla","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"2025120912413434400_ref5","doi-asserted-by":"publisher","DOI":"10.3390\/jof8111157","article-title":"Fluconazole failure in the treatment of coccidioidal meningitis","volume":"8","author":"Gupta","year":"2022","journal-title":"J Fungi"},{"key":"2025120912413434400_ref6","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1001\/archinte.1986.00360220179029","article-title":"Survival improvement in coccidioidal meningitis by high-dose intrathecal amphotericin B","volume":"146","author":"Labadie","year":"1986","journal-title":"Arch Intern Med"},{"key":"2025120912413434400_ref7","doi-asserted-by":"publisher","first-page":"e414","DOI":"10.1097\/INF.0000000000004888","article-title":"Pearls and pitfalls of intrathecal amphotericin B therapy for refractory coccidioidal meningitis in children: an illustrative pediatric case series","volume":"44","author":"Malhotra","year":"2025","journal-title":"Pediatr Infect Dis J"},{"key":"2025120912413434400_ref8","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/cid\/cir734","article-title":"Posaconazole for chronic refractory coccidioidal meningitis","volume":"53","author":"Schein","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2025120912413434400_ref9","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1097\/INF.0000000000003017","article-title":"Isavuconazole as salvage therapy for refractory pediatric coccidioidal meningitis","volume":"40","author":"Naeem","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"2025120912413434400_ref10","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S1473-3099(25)00224-5","article-title":"Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study","volume":"25","author":"Maertens","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"2025120912413434400_ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae631.032","article-title":"95. Novel antifungal olorofim use in intractable CNS and non-CNS disseminated coccidioidomycosis","volume":"12","author":"Donovan","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"2025120912413434400_ref12","doi-asserted-by":"publisher","DOI":"10.3390\/jof6040239","article-title":"Fosmanogepix: a review of the first-in-class broad spectrum agent for the treatment of invasive fungal infections","volume":"6","author":"Shaw","year":"2020","journal-title":"J Fungi"},{"key":"2025120912413434400_ref13","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00999-18","article-title":"The orotomide olorofim is efficacious in an experimental model of central nervous system coccidioidomycosis","volume":"62","author":"Wiederhold","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpids\/advance-article-pdf\/doi\/10.1093\/jpids\/piaf106\/65407953\/piaf106.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/14\/12\/piaf106\/65407953\/piaf106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/14\/12\/piaf106\/65407953\/piaf106.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T17:41:37Z","timestamp":1765302097000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/doi\/10.1093\/jpids\/piaf106\/8329238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piaf106","relation":{},"ISSN":["2048-7207"],"issn-type":[{"type":"electronic","value":"2048-7207"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,11,20]]},"article-number":"piaf106"}}